Global Renal Insufficiency Scope 2025, Forecast To 2034
26 Mar, 2025
What Fueled The Previous Growth In The Renal Insufficiency Market?
The renal insufficiency market has seen considerable growth due to a variety of factors.
• The market size for renal insufficiency has seen a dramatic rise in the last few years. It is projected to expand from $10.87 billion in 2024 to $12.14 billion in 2025, with a compound annual growth rate (CAGR) of 11.7%.
Factors contributing to the growth during the historic period include a rise in high blood pressure and diabetes cases, an increase in the incidence of chronic kidney disease (CKD), escalating cases of urinary tract obstructions, an aging population, and increased awareness and education about kidney health.
What Is The Expected Growth In The Renal Insufficiency Market Size Evolve over the Forecast Period?
The renal insufficiency market is expected to maintain its strong growth trajectory in upcoming years.
• The renal insufficiency market is set to experience considerable expansion in the coming years, with projections estimating a growth to $18.68 billion in 2029, a compound annual growth rate (CAGR) of 11.4%.
The surge through the forecast period can be linked to the rising occurrence of acute kidney injuries (AKI), the increasing popularity of home-based therapies, the increase in healthcare spending and the funding of research and development. Key trends expected within this period include medical technology advancements, progress in technology and therapy methods, the implementation of personalized medicine, developments in dialysis technology, and the creation of new and innovative drugs.
Gain Insights Into The Renal Insufficiency Global Market Report 2025 With A Free Sample Report Here:
What Main Forces Are Fueling Expansion In The Renal Insufficiency Market?
The surge of high blood pressure and diabetes incidents is projected to significantly stimulate the expansion of the renal insufficiency market in the forthcoming period. Lifestyle factors such as unhealthy dietary habits, physical inactivity, obesity, genetics, and an aging population generally contribute to high blood pressure and diabetes. High blood pressure inflicts harm on the kidney's blood vessels, leading to scarring and a decrease in filtration capacity. Diabetes, on the other hand, stresses the kidneys by thickening its vessels due to elevated blood sugar levels. This double whammy fosters an environment conducive to kidney damage, paving the way for renal insufficiency. To illustrate, the National Health Service, a UK-based government entity, unveiled data in May 2024 that exhibited a growth of 71,120 high blood pressure diagnoses in the South East in December 2023. This marked a 5.4% surge compared to the same time period the previous year. Additionally, the British Diabetic Association, a UK-based charity, disclosed in April 2023 that 4.3 million individuals in the UK had been diagnosed with diabetes. With these contributing factors in play, the rise in high blood pressure and diabetes cases is predominantly responsible for promoting the growth of the renal insufficiency market.
What Are The Primary Segments In The Global Renal Insufficiency Market?
The renal insufficiency market covered in this report is segmented –
1) By Treatment Type: Medications, Dialysis, Kidney Transplantation, Other Treatment Types
2) By Disease Stage: Chronic Kidney Disease (CKD) Stages, End-Stage Renal Disease (ESRD)
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End-User: Dialysis Centers, Hospital And Clinics, Research And Academic Institutes
Subsegments:
1) By Medications: Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Sodium Bicarbonate
2) By Dialysis: Hemodialysis, Peritoneal Dialysis, Home Dialysis, Continuous Renal Replacement Therapy (CRRT)
3) By Kidney Transplantation: Living Donor Kidney Transplant, Deceased Donor Kidney Transplant, Kidney Transplant Immunosuppressive Therapy
4) By Other Treatment Types: Lifestyle And Dietary Modifications, Stem Cell Therapy, Gene Therapy
What Emerging Trends Are Influencing The Growth Of The Renal Insufficiency Market?
Leading corporations in the renal insufficiency market are focusing their efforts on the creation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to manage renal and cardiovascular issues in patients suffering from diabetes and chronic kidney disease (CKD). These GLP-1 RAs represent a solution for better glucose control, reduction of inflammation, and minimization of oxidative stress in kidneys, consequently slowing the advancement of renal insufficiency. For example, in January 2025, Denmark's pharmaceutical firm, Novo Nordisk, secured Food and Drug Administration (FDA) endorsement for its product Ozempic (semaglutide). The drug is designed to lessen the risk of kidney disease progression, kidney failure, and cardiovascular death in adults diagnosed with type 2 diabetes and chronic kidney disease (CKD). This approval underscores the increased focus on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as a comprehensive strategy for managing diabetes and renal insufficiency, catering to vital unfulfilled needs of patients with advancing CKD.
Who Are the Key Players In The Renal Insufficiency Market?
Major companies operating in the renal insufficiency market are:
• Kaiser Permanente
• Johnson & Johnson
• Roche Holding AG
• Sanofi S.A.
• Abbott Laboratories
• Medtronic plc
• Amgen Inc.
• Asahi Kasei Medical Co. Ltd.
• Fujifilm Holdings Corporation
• Fresenius Medical Care
• Toray Industries Inc.
• Baxter International Inc.
• Boehringer Ingelheim
• DaVita Inc.
• Eisai Co. Ltd.
• Nipro Corporation
• Biocon Limited
• HemoCue AB
• Rockwell Medical
• Mitsubishi Tanabe Pharma Corporation
• Sorin Group.
What Is The Most Dominant Region In The Renal Insufficiency Market?
North America was the largest region in the renal insufficiency market in 2024. The regions covered in the renal insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.